Home / Market News / $SMG
fiscal.ai Corporate Catalyst Impact 55/100 ● positive

UBS Adjusts Price Target on Scotts Miracle-Gro to $77, Maintains Buy Rating

Nov 5, 2026, 7:13 PM UTC · Primary ticker $SMG

UBS has updated its research on The Scotts Miracle-Gro Company, increasing its price target from $70 to $77 while reiterating a Buy rating. This adjustment follows the company's recent Q4 earnings report and its fiscal 2027 guidance, suggesting a positive outlook from the analyst.

UBS, a major investment bank, has increased its price target for Scotts Miracle-Gro (SMG) from $70 to $77 and maintained its 'Buy' rating. This positive adjustment comes after the company's recent fiscal fourth-quarter earnings report and the release of its fiscal 2027 financial guidance. For traders, this signals a potentially positive short-term sentiment boost for SMG, as analyst upgrades often lead to increased investor interest. The long-term implications depend on whether SMG can meet or exceed the expectations set by its guidance and the new price target. A key opportunity for traders is to capitalize on any immediate upward movement, while the risk lies in the possibility of the market not reacting as expected or the company failing to deliver on its future guidance.

$SMG positive Price target increase and maintained Buy rating
Source: fiscal.ai
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.